Form 4 Filing for John P. Schmid

On June 15, 2026, John P. Schmid, a director at ANAPTYSBIO, INC, acquired 6,030 shares of Common Stock through the settlement of a Restricted Stock Unit (RSU). The RSU vested on the same date, subject to Mr. Schmid's continued service to the company. Each RSU represents a contingent right to one share of the company's Common Stock. Following this transaction, Mr. Schmid has 37,652 shares of Common Stock. The filing also includes a Power of Attorney document, dated June 17, 2026, authorizing representatives to execute SEC filings on behalf of Mr. Schmid.